Schedule 13G ownership disclosure
HOOKIPA PHARMA INC
Security class unavailable · CUSIP: 43906K100
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,092,799
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-022006
- Form type
- SC 13G
- Filer
- GILEAD SCIENCES, INC.
- CIK
- CIK 882095
- Filed
- Feb 12, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership